Technology, Healthcare, Financials Jan 18, 2022 04:59 PM (GMT+8) · EqualOcean
Financial Associated Press, Jan. 18 - Sinopharm announced that Sinopharm Zhijun, the holding subsidiary of the company, received the notice of approval for supplementary drug application for cefoxitin sodium for injection (1.0g) approved and issued by the food and drug administration, approving the drug to pass the consistency evaluation of generic drug quality and efficacy. Cefoxitin sodium is widely used in lower respiratory tract, urinary tract, abdominal cavity, gynecology, bone and joint, skin and soft tissue infections.

This text is a result of machine translation.